629 related articles for article (PubMed ID: 24051998)
1. Impact and effectiveness of RotaTeq® vaccine based on 3 years of surveillance following introduction of a rotavirus immunization program in Finland.
Vesikari T; Uhari M; Renko M; Hemming M; Salminen M; Torcel-Pagnon L; Bricout H; Simondon F
Pediatr Infect Dis J; 2013 Dec; 32(12):1365-73. PubMed ID: 24051998
[TBL] [Abstract][Full Text] [Related]
2. Sustained High Effectiveness of RotaTeq on Hospitalizations Attributable to Rotavirus-Associated Gastroenteritis During 4 Years in Finland.
Hemming-Harlo M; Vesikari T; Uhari M; Renko M; Salminen M; Torcel-Pagnon L; Hartwig S; Simondon F; Bricout H
J Pediatric Infect Dis Soc; 2017 Nov; 6(4):317-323. PubMed ID: 27760800
[TBL] [Abstract][Full Text] [Related]
3. Hospital bed occupancy for rotavirus and all cause acute gastroenteritis in two Finnish hospitals before and after the implementation of the national rotavirus vaccination program with RotaTeq®.
Hartwig S; Uhari M; Renko M; Bertet P; Hemming M; Vesikari T
BMC Health Serv Res; 2014 Dec; 14():632. PubMed ID: 25494641
[TBL] [Abstract][Full Text] [Related]
4. A significant and consistent reduction in rotavirus gastroenteritis hospitalization of children under 5 years of age, following the introduction of universal rotavirus immunization in Israel.
Muhsen K; Rubenstein U; Kassem E; Goren S; Schachter Y; Kremer A; Shulman LM; Ephros M; Cohen D
Hum Vaccin Immunother; 2015; 11(10):2475-82. PubMed ID: 26212174
[TBL] [Abstract][Full Text] [Related]
5. Decrease of Rotavirus Gastroenteritis to a Low Level Without Resurgence for Five Years After Universal RotaTeq Vaccination in Finland.
Hemming-Harlo M; Markkula J; Huhti L; Salminen M; Vesikari T
Pediatr Infect Dis J; 2016 Dec; 35(12):1304-1308. PubMed ID: 27455440
[TBL] [Abstract][Full Text] [Related]
6. Incidence of rotavirus gastroenteritis hospitalizations and genotypes, before and five years after introducing universal immunization in Israel.
Muhsen K; Kassem E; Rubenstein U; Goren S; Ephros M; Cohen D; Shulman LM
Vaccine; 2016 Nov; 34(48):5916-5922. PubMed ID: 27771186
[TBL] [Abstract][Full Text] [Related]
7. Rotavirus epidemiology 5-6 years after universal rotavirus vaccination: persistent rotavirus activity in older children and elderly.
Markkula J; Hemming-Harlo M; Salminen MT; Savolainen-Kopra C; Pirhonen J; Al-Hello H; Vesikari T
Infect Dis (Lond); 2017 May; 49(5):388-395. PubMed ID: 28067093
[TBL] [Abstract][Full Text] [Related]
8. Long-term surveillance of rotavirus vaccination after implementation of a national immunization program in Finland (2008-2018).
Hemming-Harlo M; Gylling A; Herse F; Haavisto I; Nuutinen M; Pasternack M; Kanibir MN; Hartwig S; Carias C
Vaccine; 2022 Jun; 40(29):3942-3947. PubMed ID: 35641360
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of 2 rotavirus vaccines against rotavirus disease in Taiwanese infants.
Chang WC; Yen C; Wu FT; Huang YC; Lin JS; Huang FC; Yu HT; Chi CL; Lin HY; Tate JE; Parashar UD; Wu HS; Hsiung CA
Pediatr Infect Dis J; 2014 Mar; 33(3):e81-6. PubMed ID: 24569388
[TBL] [Abstract][Full Text] [Related]
10. Rotavirus gastroenteritis in Finnish children in 2006-2008, at the introduction of rotavirus vaccination.
Räsänen S; Lappalainen S; Halkosalo A; Salminen M; Vesikari T
Scand J Infect Dis; 2011 Jan; 43(1):58-63. PubMed ID: 20807022
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of rotavirus pentavalent vaccine under a universal immunization programme in Israel, 2011-2015: a case-control study.
Muhsen K; Anis E; Rubinstein U; Kassem E; Goren S; Shulman LM; Ephros M; Cohen D
Clin Microbiol Infect; 2018 Jan; 24(1):53-59. PubMed ID: 28442435
[TBL] [Abstract][Full Text] [Related]
12. Clinical Severity and Rotavirus Vaccination among Children Hospitalized for Acute Gastroenteritis in Belém, Northern Brazil.
Justino MC; Brasil P; Abreu E; Miranda Y; Mascarenhas JD; Guerra SF; Linhares AC
J Trop Pediatr; 2016 Aug; 62(4):276-81. PubMed ID: 26884442
[TBL] [Abstract][Full Text] [Related]
13. Rapid impact of rotavirus vaccine introduction to the National Immunization plan in southern Israel: comparison between 2 distinct populations.
Givon-Lavi N; Ben-Shimol S; Cohen R; Greenberg D; Dagan R
Vaccine; 2015 Apr; 33(16):1934-40. PubMed ID: 25744226
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of pentavalent rotavirus vaccine in a high HIV prevalence population in Kenya.
Feikin DR; Laserson KF; Ojwando J; Nyambane G; Ssempijja V; Audi A; Nyakundi D; Oyieko J; Dallas MJ; Ciarlet M; Neuzil KM; Breiman RF
Vaccine; 2012 Apr; 30 Suppl 1():A52-60. PubMed ID: 22520137
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and immunogenicity of two or three dose rotavirus-vaccine regimen in South African children over two consecutive rotavirus-seasons: a randomized, double-blind, placebo-controlled trial.
Madhi SA; Kirsten M; Louw C; Bos P; Aspinall S; Bouckenooghe A; Neuzil KM; Steele AD
Vaccine; 2012 Apr; 30 Suppl 1():A44-51. PubMed ID: 22520136
[TBL] [Abstract][Full Text] [Related]
16. Analyses of health outcomes from the 5 sites participating in the Africa and Asia clinical efficacy trials of the oral pentavalent rotavirus vaccine.
Breiman RF; Zaman K; Armah G; Sow SO; Anh DD; Victor JC; Hille D; Ciarlet M; Neuzil KM
Vaccine; 2012 Apr; 30 Suppl 1():A24-9. PubMed ID: 22520132
[TBL] [Abstract][Full Text] [Related]
17. Hospital-based surveillance to evaluate the impact of rotavirus vaccination in São Paulo, Brazil.
Sáfadi MA; Berezin EN; Munford V; Almeida FJ; de Moraes JC; Pinheiro CF; Racz ML
Pediatr Infect Dis J; 2010 Nov; 29(11):1019-22. PubMed ID: 20543761
[TBL] [Abstract][Full Text] [Related]
18. Rotavirus vaccines in Israel: Uptake and impact.
Muhsen K; Cohen D
Hum Vaccin Immunother; 2017 Jul; 13(7):1722-1727. PubMed ID: 28281866
[TBL] [Abstract][Full Text] [Related]
19. Public health impact of accelerated immunization against rotavirus infection among children aged less than 6 months in the United States.
Weycker D; Atwood MA; Standaert B; Krishnarajah G
Hum Vaccin Immunother; 2014; 10(7):2032-8. PubMed ID: 25424813
[TBL] [Abstract][Full Text] [Related]
20. First year experience of rotavirus immunisation programme in Finland.
Leino T; Ollgren J; Salo H; Tiihonen P; Kilpi T
Vaccine; 2012 Dec; 31(1):176-82. PubMed ID: 23122991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
